FIRST AMENDMENT TO COLLABORATION AGREEMENTCollaboration Agreement • August 5th, 2020 • Zymeworks Inc. • Pharmaceutical preparations • New York
This First Amendment (the “Amendment”) to the Agreement (as defined below), is entered into as of May 25, 2020 (the “Amendment Effective Date”), by and between Zymeworks Inc., a corporation organized and existing under the laws of British Columbia (“Zymeworks”), having a place of business at 540-1385 West 8th Avenue, Vancouver, BC, Canada V6H 3V9, and BeiGene, Ltd., a Cayman Island exempted company incorporated with limited liability (“BeiGene”), having a place of business at c/o Mourant Ozannes Corporate Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, PO Box 1348, Grand Cayman KY1-1108, Cayman Islands. Zymeworks and BeiGene are each referred to individually as a “Party” and together as the “Parties”.
THIRD AMENDMENT TO COLLABORATION AGREEMENTCollaboration Agreement • August 5th, 2020 • Zymeworks Inc. • Pharmaceutical preparations • New York
This Third Amendment (the “Amendment”) to the Agreement (as defined below), is entered into as of June 22, 2020 (the “Amendment Effective Date”), by and between CELGENE CORPORATION, a corporation organized and existing under the laws of Delaware, with its principal business office located at 86 Morris Avenue, Summit, NJ 07901, USA (“Celgene Corp.”), CELGENE ALPINE INVESTMENT CO. LLC (“Celgene Alpine” and, together with Celgene Corp., “Celgene”) and ZYMEWORKS INC., a corporation organized and existing under the laws of British Columbia, having an address at 540-1385 West 8th Avenue, Vancouver, BC, Canada V6H 3V9 (“Zymeworks”). Zymeworks and Celgene are each referred to individually as a “Party” and together as the “Parties”.
